ANK2, ankyrin 2, 287

N. diseases: 71; N. variants: 37
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 Biomarker phenotype BEFREE Na<sup>+</sup> microdomains and sparks: Role in cardiac excitation-contraction coupling and arrhythmias in ankyrin-B deficiency. 30731085 2019
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE ANK2 p.Q1283H is a disease-associated variant that confers susceptibility to stress-induced arrhythmias, which may be prevented by the administration of metoprolol or flecainide. 30571258 2018
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE At the cellular level, ankyrin-B(L1622I/L1622I) myocytes display increased action potential duration and severe arrhythmogenic afterdepolarizations that provide a mechanistic rationale for the arrhythmias. 27298202 2016
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE Phenotypic Variability of ANK2 Mutations in Patients With Inherited Primary Arrhythmia Syndromes. 27784853 2016
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE Rare functional variants of ankyrin-B have been implicated in human disease, including hereditary cardiac arrhythmia and type 2 diabetes (T2D). 26168218 2015
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE βII spectrin recruits ankyrin-B to the cardiac dyad, and a novel human mutation in the ankyrin-B gene disrupts the ankyrin-B/βII spectrin interaction, leading to severe human arrhythmia phenotypes. 25632041 2015
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 Biomarker phenotype BEFREE These findings illustrate the complexity of the molecular components involved in human arrhythmia and define regulatory elements of the ankyrin-B pathway in pathophysiology. 23059182 2012
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 AlteredExpression phenotype BEFREE Moreover, loss of ankyrin-B in atrial myocytes results in decreased Ca(v)1.3 expression, membrane localization, and function sufficient to produce shortened atrial action potentials and arrhythmias. 21859974 2011
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 Biomarker phenotype BEFREE We performed a comprehensive screen of ANK2 in populations (control, congenital arrhythmia, drug-induced long-QT syndrome) of different ethnicities to discover unidentified ANK2 variants. 17242276 2007
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE Ankyrin-B variants associated with severe human arrhythmia phenotypes (eg E1425G, V1516D, R1788W) were rare in the general population. 17940615 2007
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE Human ANK2 mutations are associated with "ankyrin-B syndrome" (an atypical arrhythmia syndrome with risk of sudden cardiac death). 16800854 2006
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 Biomarker phenotype BEFREE Mutations in ANK2-encoded ankyrin-B underlie long QT syndrome type 4 (LQT4) and various other dysrhythmia phenotypes. 16253912 2005
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 Biomarker phenotype BEFREE Among these LQT models, the LQT3 and LQT4 mice exhibit spontaneous or exercise-induced life-threatening arrhythmias characteristics of long-QT patients. 15176421 2004
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE A loss-of-function mutation of ankyrin-B identified in an extended kindred causes a dominantly inherited cardiac arrhythmia, initially described as type 4 long QT syndrome. 15178757 2004
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype BEFREE Ankyrin-B mutation also leads to altered Ca2+ signalling in adult cardiomyocytes that results in extrasystoles, and provides a rationale for the arrhythmia. 12571597 2003
CUI: C0003811
Disease: Cardiac Arrhythmia
Cardiac Arrhythmia
0.100 GeneticVariation phenotype LHGDN Ankyrin-B mutation also leads to altered Ca2+ signalling in adult cardiomyocytes that results in extrasystoles, and provides a rationale for the arrhythmia. 12571597 2003